Form 4: UnitedHealth Group Executive Heather Cianfrocco Reports Stock Transactions
SEC Form 4
Heather Cianfrocco, Chief Executive Officer of Optum, reports acquisition and disposal of UnitedHealth Group common stock and stock options.
Summary
- Heather Cianfrocco, a top executive at UnitedHealth Group, filed a Form 4 detailing changes in her beneficial ownership of the company's stock.
- On February 20, 2025, she acquired 4,365 shares of common stock related to the settlement of Performance Share Awards and 3,981 restricted stock units that vest annually from 2026-2029.
- Also on February 20, 2025, she disposed of 1,698.657 shares of common stock at $502.42.
- On February 21, 2025, she disposed of 263.687, 342.154 and 396.832 shares of common stock at $466.42.
- She also acquired 16,884 non-qualified stock options exercisable from 2026-2029 at a price of $502.42.
- Following these transactions, Cianfrocco directly owns 22,392.249 shares of UnitedHealth Group common stock and 16,884 non-qualified stock options.
Sentiment
Score: 6
Explanation: Neutral sentiment as the filing primarily reflects routine stock transactions related to executive compensation. The mix of acquisitions and disposals doesn't strongly indicate positive or negative sentiment.
Positives
- The acquisition of performance shares and restricted stock units indicates confidence in the company's future performance.
Negatives
- The disposal of shares could be interpreted negatively, although it may be for personal financial management.
Risks
- Executive stock transactions can sometimes signal internal views on company performance, although this filing appears routine.
Future Outlook
The vesting schedules for restricted stock units and stock options suggest a long-term commitment to the company.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies and are regularly monitored by investors for insights into management's perspective on the company's value and prospects.
Comparison to Industry Standards
- Executive compensation packages at UnitedHealth Group, including stock options and restricted stock units, are likely benchmarked against those of other large healthcare and insurance companies such as CVS Health, Anthem (Elevance Health), and Cigna.
- The vesting schedules and exercise prices of stock options are typically designed to align executive interests with long-term shareholder value creation, similar to practices observed at peer companies.
Stakeholder Impact
- The transactions may have a minor impact on shareholders' perception of the company, depending on how they interpret the executive's stock disposals.
Key Dates
| Date | Description |
|---|---|
| 02/20/2025 | Date of earliest transaction; acquisition of shares and stock options, disposal of shares. |
| 02/21/2025 | Date of disposal of shares. |
| 02/20/2026 | First vesting date for restricted stock units and non-qualified stock options. |
| 02/20/2029 | Last vesting date for restricted stock units and non-qualified stock options. |
| 02/20/2035 | Expiration date for non-qualified stock options. |
| 02/24/2025 | Date of signature on the Form 4 filing. |
Keywords
UnitedHealth Group, UNH, stock options, Form 4, Cianfrocco, Optum, stock, executive compensation, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.